SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-08-10 15:09
Tx date 2022-07-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-110,545 vol
0
Filed 2022-08-10 15:09
Tx date 2022-07-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$244,304
+110,545 vol
$2.21 each
110,545
Filed 2022-07-18 12:53
Tx date 2022-07-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,020
+1,836 vol
$2.19 each
332,844
Filed 2022-07-18 12:51
Tx date 2022-07-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,079
+493 vol
$2.19 each
110,379
Filed 2022-07-12 14:51
Tx date 2022-06-30
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-123,000 vol
0
Filed 2022-07-12 14:51
Tx date 2022-06-30
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$290,280
+123,000 vol
$2.36 each
123,000
Filed 2022-06-21 09:51
Tx date 2022-06-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,032
+1,716 vol
$2.35 each
331,008
Filed 2022-06-21 09:48
Tx date 2022-06-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,083
+461 vol
$2.35 each
109,886
Filed 2022-06-10 11:52
Tx date 2022-05-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-140,900 vol
0
Filed 2022-06-10 11:52
Tx date 2022-05-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$332,524
+140,900 vol
$2.36 each
140,900
Filed 2022-05-26 11:29
Tx date 2022-05-20
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$917.39
+461 vol
$1.99 each
109,425
Filed 2022-05-26 11:27
Tx date 2022-05-20
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,414
+1,716 vol
$1.99 each
329,292
Filed 2022-05-10 12:02
Tx date 2022-04-30
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-137,400 vol
0
Filed 2022-05-10 12:01
Tx date 2022-04-30
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$331,134
+137,400 vol
$2.41 each
137,400
Filed 2022-04-26 14:19
Tx date 2022-04-20
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$917.51
+439 vol
$2.09 each
108,964
Filed 2022-04-26 14:16
Tx date 2022-04-20
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,415
+1,634 vol
$2.09 each
327,576
Filed 2022-04-11 20:12
Tx date 2022-03-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-196,300 vol
0
Filed 2022-04-11 20:12
Tx date 2022-03-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$429,897
+196,300 vol
$2.19 each
196,300
Filed 2022-04-04 19:19
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,552 vol
69,996
Filed 2022-04-04 19:19
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-24,603 vol
71,548
Filed 2022-04-04 19:18
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$3,243
+1,552 vol
$2.09 each
51,817
Filed 2022-04-04 19:17
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$55,356
+24,603 vol
$2.25 each
50,265
Filed 2022-04-04 19:15
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-7,500 vol
5,376
Filed 2022-04-04 19:14
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$15,674
+7,500 vol
$2.09 each
325,942
Filed 2022-04-04 19:13
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-2,500 vol
2,500
Filed 2022-04-04 19:12
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$5,225
+2,500 vol
$2.09 each
2,500
Filed 2022-04-04 19:12
Tx date 2020-10-08
$CPH
Cipher Pharmaceuticals Inc.
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-04-04 19:10
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-2,500 vol
242,283
Filed 2022-04-04 19:09
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-14,112 vol
244,783
Filed 2022-04-04 19:08
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$31,752
+14,112 vol
$2.25 each
457,084
Filed 2022-04-04 19:08
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$5,225
+2,500 vol
$2.09 each
442,972
Filed 2022-04-04 19:05
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-2,500 vol
0
Filed 2022-04-04 19:05
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$5,225
+2,500 vol
$2.09 each
249,040
Filed 2022-04-04 19:03
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-2,500 vol
0
Filed 2022-04-04 19:02
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$5,225
+2,500 vol
$2.09 each
108,525
Filed 2022-04-04 18:57
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-2,500 vol
5,000
Filed 2022-04-04 18:55
Tx date 2022-04-01
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$5,225
+2,500 vol
$2.09 each
490,355
Filed 2022-03-30 14:46
Tx date 2022-03-17
$CPH
Cipher Pharmaceuticals Inc.
Langille, Scott
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+18,546 vol
18,546
Filed 2022-03-30 14:45
Tx date 2020-07-03
$CPH
Cipher Pharmaceuticals Inc.
Langille, Scott
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-30 14:44
Tx date 2022-03-17
$CPH
Cipher Pharmaceuticals Inc.
Langille, Scott
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$5,952
+2,743 vol
$2.17 each
52,743
Filed 2022-03-30 14:40
Tx date 2022-03-17
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+24,260 vol
96,151
Filed 2022-03-30 14:39
Tx date 2022-03-17
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$103,452
+47,674 vol
$2.17 each
195,089
Filed 2022-03-30 14:37
Tx date 2022-03-17
$CPH
Cipher Pharmaceuticals Inc.
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+2,500 vol
5,000
Filed 2022-03-30 14:36
Tx date 2022-03-17
$CPH
Cipher Pharmaceuticals Inc.
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$10,850
+5,000 vol
$2.17 each
30,000
Filed 2022-03-30 14:33
Tx date 2022-03-17
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+216,059 vol
258,895
Filed 2022-03-30 14:31
Tx date 2022-03-17
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$341,866
+157,542 vol
$2.17 each
221,443
Filed 2022-03-30 14:28
Tx date 2022-03-17
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+2,500 vol
2,500
Filed 2022-03-30 14:27
Tx date 2022-03-17
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$10,850
+5,000 vol
$2.17 each
34,021
Filed 2022-03-30 14:25
Tx date 2022-03-17
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+7,500 vol
12,876
Filed 2022-03-30 14:24
Tx date 2022-03-17
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$10,850
+5,000 vol
$2.17 each
37,521
Filed 2022-03-30 14:21
Tx date 2022-03-17
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+2,500 vol
2,500
Filed 2022-03-30 14:20
Tx date 2022-03-17
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$10,850
+5,000 vol
$2.17 each
37,521
Filed 2022-03-30 14:17
Tx date 2022-03-17
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options
$10,850
+5,000 vol
$2.17 each
7,500
Filed 2022-03-30 14:10
Tx date 2022-03-17
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+2,500 vol
2,500
Filed 2022-03-21 13:34
Tx date 2022-03-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,415
+2,070 vol
$1.65 each
318,442
Filed 2022-03-11 12:34
Tx date 2022-02-28
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-136,500 vol
0
Filed 2022-03-11 12:33
Tx date 2022-02-28
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$282,555
+136,500 vol
$2.07 each
136,500
Filed 2022-02-20 12:54
Tx date 2022-02-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,415
+1,908 vol
$1.79 each
316,372
Filed 2022-02-11 15:07
Tx date 2022-01-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-130,300 vol
0
Filed 2022-02-11 15:06
Tx date 2022-01-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$233,237
+130,300 vol
$1.79 each
130,300
Filed 2022-01-20 17:00
Tx date 2022-01-17
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,115
+5,121 vol
$1.78 each
314,464
Filed 2022-01-10 14:36
Tx date 2021-12-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-156,200 vol
0
Filed 2022-01-10 14:22
Tx date 2021-12-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$279,598
+156,200 vol
$1.79 each
156,200
Filed 2021-12-14 14:18
Tx date 2021-11-30
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-161,200 vol
0
Filed 2021-12-14 14:16
Tx date 2021-11-30
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$375,596
+161,200 vol
$2.33 each
161,200
Filed 2021-11-18 10:01
Tx date 2021-11-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,563
+1,967 vol
$2.32 each
309,343
Filed 2021-11-10 14:08
Tx date 2021-10-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-132,800 vol
0
Filed 2021-11-10 14:07
Tx date 2021-10-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$333,328
+132,800 vol
$2.51 each
132,800
Filed 2021-10-20 11:54
Tx date 2021-10-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,551
+1,828 vol
$2.49 each
307,376
Filed 2021-10-13 10:40
Tx date 2021-09-30
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-116,300 vol
0
Filed 2021-10-13 10:38
Tx date 2021-09-30
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$286,098
+116,300 vol
$2.46 each
116,300
Filed 2021-09-20 16:46
Tx date 2021-09-20
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,552
+1,881 vol
$2.42 each
305,548
Filed 2021-09-13 12:40
Tx date 2021-08-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-40,500 vol
0
Filed 2021-09-13 12:38
Tx date 2021-08-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$58,684
+36,450 vol
$1.61 each
40,500
Filed 2021-09-13 12:36
Tx date 2021-08-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,520
+4,050 vol
$1.61 each
4,050
Filed 2021-08-20 11:15
Tx date 2021-08-20
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,570
+2,320 vol
$1.97 each
303,667
Filed 2021-08-13 09:55
Tx date 2021-07-30
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$-121,317
-76,300 vol
$1.59 each
0
Filed 2021-08-13 09:53
Tx date 2021-07-30
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$121,317
+76,300 vol
$1.59 each
76,300
Filed 2021-07-27 12:43
Tx date 2021-07-20
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,548
+2,808 vol
$1.62 each
301,347
Filed 2021-07-27 12:41
Tx date 2021-07-20
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,056
+652 vol
$1.62 each
106,025
Filed 2021-07-13 10:54
Tx date 2021-06-30
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-145,900 vol
0
Filed 2021-07-13 10:53
Tx date 2021-06-30
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$230,522
+145,900 vol
$1.58 each
145,900
Filed 2021-06-22 12:38
Tx date 2021-06-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,875
+2,768 vol
$1.40 each
298,539
Filed 2021-06-21 11:56
Tx date 2021-06-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$900.20
+643 vol
$1.40 each
105,373
Filed 2021-06-11 11:39
Tx date 2021-05-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-102,000 vol
0
Filed 2021-06-11 11:37
Tx date 2021-05-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$141,780
+102,000 vol
$1.39 each
102,000
Filed 2021-06-04 11:52
Tx date 2021-03-21
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-24,603 vol
71,891
Filed 2021-06-04 11:48
Tx date 2021-03-21
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-15,613 vol
42,836
Filed 2021-06-04 10:43
Tx date 2021-03-21
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
0
Filed 2021-06-04 10:39
Tx date 2021-03-21
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
5,376
Filed 2021-06-04 10:36
Tx date 2021-03-21
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
0
Filed 2021-06-04 10:34
Tx date 2021-03-21
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
0
Filed 2021-05-28 14:40
Tx date 2021-05-28
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,578
+3,202 vol
$1.43 each
295,771
Filed 2021-05-28 14:38
Tx date 2021-05-28
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,063
+744 vol
$1.43 each
104,730
Filed 2021-05-26 10:23
Tx date 2021-03-21
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$25,833
+24,603 vol
$1.05 each
25,662
Filed 2021-05-26 10:21
Tx date 2021-03-21
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$1,575
+1,500 vol
$1.05 each
289,199
Filed 2021-05-26 10:19
Tx date 2021-03-21
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$1,575
+1,500 vol
$1.05 each
80,204
Filed 2021-05-26 10:17
Tx date 2021-03-21
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$1,575
+1,500 vol
$1.05 each
246,540
Filed 2021-05-26 09:41
Tx date 2021-03-21
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$16,393
+15,613 vol
$1.05 each
440,472
Filed 2021-05-26 09:37
Tx date 2021-03-21
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$1,575
+1,500 vol
$1.05 each
487,855
Filed 2021-05-11 10:27
Tx date 2021-04-30
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-129,400 vol
0
Filed 2021-05-11 10:25
Tx date 2021-04-30
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$173,396
+129,400 vol
$1.34 each
129,400
Filed 2021-04-26 17:51
Tx date 2021-03-18
$CPH
Cipher Pharmaceuticals Inc.
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$4,500
+5,000 vol
$0.90 each
25,000
Filed 2021-04-23 10:25
Tx date 2021-04-16
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,549
+3,370 vol
$1.35 each
291,069
Filed 2021-04-23 10:22
Tx date 2021-04-16
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,055
+782 vol
$1.35 each
102,486
Filed 2021-04-15 17:32
Tx date 2021-03-18
$CPH
Cipher Pharmaceuticals Inc.
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options

+2,500 vol
2,500
Filed 2021-04-15 17:27
Tx date 2020-10-08
$CPH
Cipher Pharmaceuticals Inc.
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2021-04-01 19:43
Tx date 2021-03-18
$CPH
Cipher Pharmaceuticals Inc.
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$1,125
+1,250 vol
$0.90 each
Filed 2021-04-13 17:05
Tx date 2021-03-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-18,200 vol
0
Filed 2021-04-13 17:04
Tx date 2021-03-31
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$23,660
+18,200 vol
$1.30 each
18,200
Filed 2021-04-01 19:43
Tx date 2021-03-18
$CPH
Cipher Pharmaceuticals Inc.
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$1,125
+1,250 vol
$0.90 each
21,250
Filed 2021-03-26 14:41
Tx date 2021-03-26
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,720
+4,000 vol
$1.18 each
101,704
Filed 2021-03-26 09:54
Tx date 2021-03-23
$CPH
Cipher Pharmaceuticals Inc.
Langille, Scott
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$31,250
+25,000 vol
$1.25 each
25,000
Filed 2021-03-26 09:52
Tx date 2020-07-03
$CPH
Cipher Pharmaceuticals Inc.
Langille, Scott
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-25 13:41
Tx date 2021-03-25
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,770
+7,000 vol
$1.11 each
97,704
Filed 2021-03-25 13:40
Tx date 2021-03-23
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,880
+12,000 vol
$1.24 each
90,704
Filed 2021-03-16 12:51
Tx date 2021-03-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,589
+5,099 vol
$0.90 each
287,699
Filed 2021-03-16 12:48
Tx date 2021-03-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,065
+1,184 vol
$0.90 each
78,704
Filed 2021-03-05 14:13
Tx date 2021-01-04
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-132,000 vol
0
Filed 2021-03-05 14:13
Tx date 2020-12-29
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$115,090
+132,000 vol
$0.87 each
132,000
Filed 2021-03-05 12:05
Tx date 2020-11-27
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-73,500 vol
0
Filed 2021-03-05 12:04
Tx date 2020-11-26
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$68,840
+73,500 vol
$0.94 each
73,500
Filed 2021-03-05 11:55
Tx date 2020-09-29
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-30,000 vol
0
Filed 2021-03-05 11:54
Tx date 2020-09-28
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$34,038
+30,000 vol
$1.13 each
30,000
Filed 2021-03-05 11:51
Tx date 2004-01-09
$CPH
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-22 11:03
Tx date 2021-02-16
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,875
+4,726 vol
$0.82 each
282,600
Filed 2021-02-22 11:00
Tx date 2021-02-16
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$899.54
+1,097 vol
$0.82 each
77,520
Filed 2021-01-25 10:51
Tx date 2021-01-18
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,576
+4,123 vol
$1.11 each
277,874
Filed 2021-01-25 10:48
Tx date 2021-01-18
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,062
+957 vol
$1.11 each
76,423
Filed 2020-12-17 15:10
Tx date 2020-12-16
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,927
+5,455 vol
$0.72 each
273,751
Filed 2020-12-17 15:07
Tx date 2020-12-16
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$888.48
+1,234 vol
$0.72 each
75,466
Filed 2020-12-01 15:18
Tx date 2020-12-01
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,480
+4,000 vol
$0.87 each
74,232
Filed 2020-11-19 11:40
Tx date 2020-11-12
$CPH
Cipher Pharmaceuticals Inc.
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$18,600
+20,000 vol
$0.93 each
20,000
Filed 2020-11-19 11:36
Tx date 2020-10-08
$CPH
Cipher Pharmaceuticals Inc.
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-11-19 09:31
Tx date 2020-11-12
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
$4,999
+5,376 vol
$0.93 each
6,876
Filed 2020-11-17 10:20
Tx date 2020-11-17
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,936
+4,860 vol
$0.81 each
268,296
Filed 2020-11-17 10:16
Tx date 2020-11-17
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$888.57
+1,097 vol
$0.81 each
70,232
Filed 2020-11-11 22:47
Tx date 2020-10-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,151
+3,426 vol
$0.92 each
263,436
Filed 2020-11-11 22:45
Tx date 2020-10-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$860.20
+935 vol
$0.92 each
69,135
Filed 2020-09-18 14:48
Tx date 2020-09-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,881
+3,961 vol
$0.98 each
260,010
Filed 2020-09-18 14:44
Tx date 2020-09-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$901.60
+920 vol
$0.98 each
68,200
Filed 2020-09-08 13:46
Tx date 2020-05-26
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+829 vol
424,859
Filed 2020-05-29 16:53
Tx date 2020-05-26
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+806 vol
Filed 2020-08-19 10:50
Tx date 2020-08-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,552
+6,625 vol
$1.14 each
256,049
Filed 2020-08-19 10:42
Tx date 2020-08-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,790
+1,571 vol
$1.14 each
67,280
Filed 2020-08-17 15:15
Tx date 2020-08-12
$CPH
Cipher Pharmaceuticals Inc.
Langille, Scott
5 - Senior Officer of Issuer
Direct Ownership
Options
56 - Grant of rights
$250.00
+25,000 vol
$0.01 each
50,000
Filed 2020-08-17 14:44
Tx date 2020-08-12
$CPH
Cipher Pharmaceuticals Inc.
Langille, Scott
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$35,750
+25,000 vol
$1.43 each
25,000
Filed 2020-08-17 14:36
Tx date 2020-07-03
$CPH
Cipher Pharmaceuticals Inc.
Langille, Scott
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-06-25 23:07
Tx date 2020-06-23
$CPH
Cipher Pharmaceuticals Inc.
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-13,604.76
-11,934 vol
$1.14 each
0
Filed 2020-06-16 14:16
Tx date 2020-06-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,587
+3,552 vol
$1.01 each
249,424
Filed 2020-06-16 14:14
Tx date 2020-06-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$869.61
+861 vol
$1.01 each
65,709
Filed 2020-05-29 16:53
Tx date 2020-05-26
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+806 vol
424,836
Filed 2020-05-29 16:52
Tx date 2020-05-26
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
58,449
Filed 2020-05-29 16:51
Tx date 2020-05-26
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+478 vol
486,355
Filed 2020-05-29 16:50
Tx date 2020-05-26
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-866 vol
1,500
Filed 2020-05-29 16:49
Tx date 2020-05-26
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+866 vol
64,848
Filed 2020-05-29 16:48
Tx date 2020-05-26
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-866 vol
1,500
Filed 2020-05-29 16:46
Tx date 2020-05-26
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,059 vol
1,059
Filed 2020-05-29 16:46
Tx date 2018-06-04
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-29 16:45
Tx date 2020-05-26
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,916 vol
96,494
Filed 2020-05-29 16:41
Tx date 2020-05-26
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+478 vol
245,040
Filed 2020-05-29 16:40
Tx date 2020-05-26
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-866 vol
1,500
Filed 2020-05-29 16:35
Tx date 2020-05-26
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+478 vol
245,872
Filed 2020-05-29 16:34
Tx date 2020-05-26
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-866 vol
1,500
Filed 2020-05-29 16:32
Tx date 2020-05-26
$CPH
Cipher Pharmaceuticals Inc.
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,810 vol
11,934
Filed 2020-05-29 16:31
Tx date 2020-05-26
$CPH
Cipher Pharmaceuticals Inc.
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-6,891 vol
98,632
Filed 2020-05-20 16:40
Tx date 2020-05-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,632
+3,427 vol
$1.06 each
245,394
Filed 2020-05-20 16:37
Tx date 2020-05-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$881.92
+832 vol
$1.06 each
63,982
Filed 2020-05-11 17:00
Tx date 2020-05-07
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+1,500 vol
59,949
Filed 2020-05-11 16:58
Tx date 2020-05-07
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$3,150
+3,500 vol
$0.90 each
63,901
Filed 2020-05-11 16:46
Tx date 2020-05-07
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+1,500 vol
2,366
Filed 2020-05-11 16:44
Tx date 2020-05-07
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$3,150
+3,500 vol
$0.90 each
29,021
Filed 2020-05-11 16:42
Tx date 2020-05-07
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+1,500 vol
2,366
Filed 2020-05-11 16:32
Tx date 2020-05-07
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$3,150
+3,500 vol
$0.90 each
32,521
Filed 2020-05-11 16:29
Tx date 2020-05-07
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+1,500 vol
2,366
Filed 2020-05-11 16:21
Tx date 2020-05-07
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$3,150
+3,500 vol
$0.90 each
32,521
Filed 2020-05-11 16:19
Tx date 2020-05-07
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+1,500 vol
2,366
Filed 2020-05-11 16:16
Tx date 2020-05-07
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Options
50 - Grant of options
$3,150
+3,500 vol
$0.90 each
35,021
Filed 2020-04-21 09:23
Tx date 2020-04-16
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$883.50
+1,425 vol
$0.62 each
63,150
Filed 2020-04-21 09:22
Tx date 2020-04-16
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,646
+5,882 vol
$0.62 each
241,967
Filed 2020-04-21 09:19
Tx date 2020-04-16
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$912.64
+1,472 vol
$0.62 each
Filed 2020-04-21 09:18
Tx date 2020-04-16
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$912.64
+1,472 vol
$0.62 each
Filed 2020-04-12 10:32
Tx date 2020-04-08
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+56,449 vol
58,449
Filed 2020-04-12 10:31
Tx date 2020-04-08
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$29,088
+40,401 vol
$0.72 each
60,401
Filed 2020-04-12 10:28
Tx date 2020-04-08
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+90,747 vol
98,410
Filed 2020-04-12 10:27
Tx date 2020-04-08
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$46,669
+64,819 vol
$0.72 each
147,415
Filed 2020-04-12 10:24
Tx date 2020-04-08
$CPH
Cipher Pharmaceuticals Inc.
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+82,934 vol
105,523
Filed 2020-04-12 10:20
Tx date 2020-04-08
$CPH
Cipher Pharmaceuticals Inc.
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$42,652
+59,239 vol
$0.72 each
114,538
Filed 2020-03-18 11:46
Tx date 2020-03-16
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,637
+6,062 vol
$0.60 each
236,085
Filed 2020-03-18 11:44
Tx date 2020-03-16
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$883.20
+1,472 vol
$0.60 each
61,725
Filed 2020-02-21 15:58
Tx date 2020-02-18
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,632
+4,224 vol
$0.86 each
230,023
Filed 2020-02-21 15:57
Tx date 2020-02-18
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$882.36
+1,026 vol
$0.86 each
60,253
Filed 2020-01-20 09:44
Tx date 2020-01-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,615
+3,411 vol
$1.06 each
225,799
Filed 2020-01-20 09:43
Tx date 2020-01-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$882.98
+833 vol
$1.06 each
59,227
Filed 2019-12-16 08:19
Tx date 2019-12-16
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,906
+4,651 vol
$0.84 each
222,388
Filed 2019-12-16 08:16
Tx date 2019-12-16
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$882.00
+1,050 vol
$0.84 each
58,394
Filed 2019-11-18 16:40
Tx date 2019-11-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,907
+3,757 vol
$1.04 each
217,737
Filed 2019-11-18 16:39
Tx date 2019-11-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$881.92
+848 vol
$1.04 each
57,344
Filed 2019-10-25 17:14
Tx date 2019-10-21
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,719
+3,476 vol
$1.07 each
213,980
Filed 2019-10-25 17:13
Tx date 2019-10-21
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$880.61
+823 vol
$1.07 each
56,496
Filed 2019-09-25 10:08
Tx date 2019-09-16
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,629
+2,975 vol
$1.22 each
210,504
Filed 2019-09-25 10:08
Tx date 2019-08-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,637
+3,566 vol
$1.02 each
207,529
Filed 2019-09-25 10:05
Tx date 2019-09-16
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$880.84
+722 vol
$1.22 each
55,673
Filed 2019-09-25 10:04
Tx date 2019-08-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$881.28
+864 vol
$1.02 each
51,951
Filed 2019-08-26 16:19
Tx date 2019-08-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$449.82
+441 vol
$1.02 each
Filed 2019-08-26 15:42
Tx date 2019-08-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,279
+3,566 vol
$1.20 each
Filed 2019-08-26 16:19
Tx date 2019-08-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$449.82
+441 vol
$1.02 each
51,528
Filed 2019-08-26 15:42
Tx date 2019-08-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,279
+3,566 vol
$1.20 each
207,529
Filed 2019-08-24 22:33
Tx date 2019-08-22
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$23,674
+24,800 vol
$0.95 each
244,562
Filed 2019-08-24 22:30
Tx date 2019-08-21
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,492
+11,200 vol
$0.94 each
219,762
Filed 2019-08-24 22:29
Tx date 2019-08-20
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$17,046
+18,200 vol
$0.94 each
208,562
Filed 2019-08-24 22:28
Tx date 2019-08-19
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$17,015
+18,000 vol
$0.95 each
190,362
Filed 2019-08-21 17:19
Tx date 2019-08-16
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$20,704
+17,300 vol
$1.20 each
172,362
Filed 2019-08-21 17:18
Tx date 2019-08-15
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$59,200
+50,000 vol
$1.18 each
155,062
Filed 2019-08-19 14:07
Tx date 2019-08-19
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,600
+3,000 vol
$1.20 each
54,087
Filed 2019-08-09 12:09
Tx date 2019-08-08
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+2,000 vol
2,000
Filed 2019-08-09 12:07
Tx date 2019-03-26
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2019-08-09 12:01
Tx date 2019-08-08
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$23,600
+20,000 vol
$1.18 each
20,000
Filed 2019-08-09 11:58
Tx date 2019-03-26
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-07-22 20:27
Tx date 2019-07-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,385
+3,255 vol
$1.04 each
203,963
Filed 2019-07-22 20:25
Tx date 2019-07-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$869.44
+836 vol
$1.04 each
51,087
Filed 2019-06-28 09:50
Tx date 2019-06-28
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,960
+3,000 vol
$1.32 each
50,251
Filed 2019-06-21 13:19
Tx date 2019-06-17
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,479
+7,262 vol
$1.03 each
200,708
Filed 2019-06-21 13:14
Tx date 2019-06-17
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,707
+1,658 vol
$1.03 each
43,251
Filed 2019-06-20 13:36
Tx date 2019-06-20
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,680
+4,000 vol
$1.17 each
45,593
Filed 2019-04-26 09:02
Tx date 2019-03-21
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+866 vol
2,366
Filed 2019-04-26 08:55
Tx date 2019-03-21
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+2,021 vol
29,021
Filed 2019-04-23 22:30
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+866 vol
866
Filed 2019-04-23 22:29
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+866 vol
866
Filed 2019-04-23 22:28
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Milloy, Michael
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+948 vol
948
Filed 2019-04-23 22:27
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+7,663 vol
7,663
Filed 2019-04-23 22:26
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+25,450 vol
47,461
Filed 2019-04-23 22:25
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+55,973 vol
96,697
Filed 2019-04-23 22:24
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+866 vol
866
Filed 2019-04-23 22:23
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$2,991
+2,021 vol
$1.48 each
25,521
Filed 2019-04-23 22:22
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+866 vol
866
Filed 2019-04-23 22:21
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$2,991
+2,021 vol
$1.48 each
22,021
Filed 2019-04-23 22:19
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+12,846 vol
22,589
Filed 2019-04-23 22:19
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+866 vol
866
Filed 2019-04-23 22:18
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$2,991
+2,021 vol
$1.48 each
29,021
Filed 2019-04-23 22:16
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options

+866 vol
Filed 2019-04-23 22:14
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$2,991
+2,021 vol
$1.48 each
29,021
Filed 2019-04-23 22:12
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options

+866 vol
Filed 2019-04-23 22:11
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Options
50 - Grant of options
$2,991
+2,021 vol
$1.48 each
31,521
Filed 2019-04-23 18:51
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Milloy, Michael
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options

+948 vol
Filed 2019-04-23 18:51
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Milloy, Michael
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options

+948 vol
948
Filed 2019-04-23 18:50
Tx date 2018-12-03
$CPH
Cipher Pharmaceuticals Inc.
Milloy, Michael
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-23 18:50
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Milloy, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$4,916
+3,322 vol
$1.48 each
43,322
Filed 2019-04-23 18:48
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options

+7,663 vol
7,663
Filed 2019-04-23 18:48
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options

+7,663 vol
Filed 2019-04-23 18:48
Tx date 2018-06-04
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-23 18:47
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$39,745
+26,855 vol
$1.48 each
82,596
Filed 2019-04-23 18:46
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options

+25,450 vol
Filed 2019-04-23 18:46
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options

+25,450 vol
47,461
Filed 2019-04-23 18:45
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$56,574
+38,226 vol
$1.48 each
114,221
Filed 2019-04-23 18:44
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options

+55,973 vol
96,697
Filed 2019-04-23 18:44
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options

+55,973 vol
Filed 2019-04-23 18:42
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$290,327
+196,167 vol
$1.48 each
484,181
Filed 2019-04-23 17:57
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$290,327
+196,167 vol
$1.48 each
Filed 2019-04-23 17:57
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$290,327
+196,167 vol
$1.48 each
484,181
Filed 2019-04-23 17:55
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options

+12,846 vol
22,589
Filed 2019-04-23 17:55
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options

+12,846 vol
Filed 2019-04-23 17:54
Tx date 2019-04-11
$CPH
Cipher Pharmaceuticals Inc.
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$28,556
+19,295 vol
$1.48 each
55,299
Filed 2019-04-18 11:56
Tx date 2019-04-15
$CPH
Cipher Pharmaceuticals Inc.
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$100.28
+92 vol
$1.09 each
8,124
Filed 2019-04-18 11:55
Tx date 2019-04-15
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$500.31
+459 vol
$1.09 each
8,073
Filed 2019-04-18 11:54
Tx date 2019-04-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,522
+3,232 vol
$1.09 each
193,446
Filed 2019-04-18 11:52
Tx date 2019-04-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$820.77
+753 vol
$1.09 each
41,593
Filed 2019-04-18 10:31
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,077.48
-738 vol
$1.46 each
94,922
Filed 2019-04-18 10:31
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,077.48
-738 vol
$1.46 each
94,922
Filed 2019-04-18 10:27
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,500 vol
95,660
Filed 2019-04-18 10:27
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,500 vol
95,660
Filed 2019-04-18 10:24
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
0
Filed 2019-04-18 10:24
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
0
Filed 2019-04-18 10:13
Tx date 2019-04-15
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,946
+4,538 vol
$1.09 each
99,460
Filed 2019-04-18 10:13
Tx date 2019-04-15
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,946
+4,538 vol
$1.09 each
99,460
Filed 2019-04-17 13:26
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+2,596 vol
8,032
Filed 2019-04-17 13:26
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-5,102 vol
9,743
Filed 2019-04-17 13:11
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,500 vol
190,214
Filed 2019-04-17 13:10
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
0
Filed 2019-04-17 13:09
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+2,635 vol
7,614
Filed 2019-04-17 13:08
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-5,187 vol
22,011
Filed 2019-04-17 13:06
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+7,593 vol
44,606
Filed 2019-04-17 13:04
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-14,947 vol
40,724
Filed 2019-04-17 12:53
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+741 vol
741
Filed 2019-04-17 12:53
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+741 vol
Filed 2019-04-17 12:52
Tx date 2018-05-11
$CPH
Cipher Pharmaceuticals Inc.
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-17 12:42
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
0
Filed 2019-04-17 12:40
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+762 vol
485,877
Filed 2019-04-17 12:37
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
0
Filed 2019-04-17 12:36
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+762 vol
40,840
Filed 2019-04-17 12:35
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
0
Filed 2019-04-17 12:32
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
0
Filed 2019-04-17 11:54
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,500 vol
41,578
Filed 2019-04-17 11:54
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,500 vol
Filed 2019-04-17 11:53
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
Filed 2019-04-17 11:53
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
0
Filed 2019-04-17 11:46
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
Filed 2019-04-17 11:46
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
0
Filed 2019-04-17 11:45
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+762 vol
105,062
Filed 2019-04-17 11:43
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
Filed 2019-04-17 11:43
Tx date 2019-04-01
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
Filed 2019-04-02 21:05
Tx date 2019-03-29
$CPH
Cipher Pharmaceuticals Inc.
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
5,436
Filed 2019-04-02 20:56
Tx date 2019-03-29
$CPH
Cipher Pharmaceuticals Inc.
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
14,845
Filed 2019-04-02 20:54
Tx date 2019-03-29
$CPH
Cipher Pharmaceuticals Inc.
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
36,004
Filed 2019-04-01
Tx date 2019-03-26
$CPH
Cipher Pharmaceuticals Inc.
Mull, Craig
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
424,030
Filed 2019-03-20
Tx date 2019-03-15
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,040
+3,231 vol
$1.56 each
94,160
Filed 2019-03-19
Tx date 2019-03-15
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$499.20
+320 vol
$1.56 each
4,979
Filed 2019-03-19
Tx date 2019-03-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,625
+2,324 vol
$1.56 each
188,714
Filed 2019-03-19
Tx date 2019-03-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$847.08
+543 vol
$1.56 each
40,078
Filed 2019-03-19
Tx date 2019-03-15
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$299.52
+192 vol
$1.56 each
24,550
Filed 2019-02-20
Tx date 2019-02-15
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,053
+3,139 vol
$1.61 each
90,929
Filed 2019-02-19
Tx date 2019-02-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,632
+2,256 vol
$1.61 each
186,390
Filed 2019-02-19
Tx date 2019-02-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$846.86
+526 vol
$1.61 each
39,535
Filed 2019-02-19
Tx date 2019-02-15
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$299.46
+186 vol
$1.61 each
24,358
Filed 2019-02-19
Tx date 2019-02-15
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$500.71
+311 vol
$1.61 each
4,659
Filed 2019-01-17
Tx date 2019-01-15
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,012
+3,038 vol
$1.65 each
87,790
Filed 2019-01-17
Tx date 2019-01-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$846.45
+513 vol
$1.65 each
39,009
Filed 2019-01-17
Tx date 2019-01-15
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$499.95
+303 vol
$1.65 each
4,348
Filed 2019-01-17
Tx date 2019-01-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,611
+2,189 vol
$1.65 each
184,134
Filed 2019-01-17
Tx date 2019-01-15
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,262
+765 vol
$1.65 each
24,172
Filed 2018-12-21
Tx date 2018-12-20
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$68,000
+40,000 vol
$1.70 each
435,115
Filed 2018-12-21
Tx date 2018-12-21
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$85,000
+50,000 vol
$1.70 each
485,115
Filed 2018-12-20
Tx date 2018-12-17
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$892.41
+591 vol
$1.51 each
38,496
Filed 2018-12-20
Tx date 2018-12-17
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,871
+2,564 vol
$1.51 each
181,945
Filed 2018-12-20
Tx date 2018-12-17
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,262
+836 vol
$1.51 each
23,407
Filed 2018-12-20
Tx date 2018-12-17
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,392
+3,571 vol
$1.51 each
84,752
Filed 2018-12-20
Tx date 2018-12-19
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$17,100
+10,000 vol
$1.71 each
395,115
Filed 2018-12-20
Tx date 2018-12-17
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$499.81
+331 vol
$1.51 each
4,045
Filed 2018-12-18
Tx date 2018-12-03
$CPH
Cipher Pharmaceuticals Inc.
Milloy, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-12-18
Tx date 2018-12-14
$CPH
Cipher Pharmaceuticals Inc.
Milloy, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$70,000
+40,000 vol
$1.75 each
40,000
Filed 2018-11-20
Tx date 2018-11-15
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,262
+836 vol
$1.51 each
22,571
Filed 2018-11-20
Tx date 2018-11-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$845.60
+560 vol
$1.51 each
37,905
Filed 2018-11-20
Tx date 2018-11-15
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,262
+836 vol
$1.51 each
Filed 2018-11-20
Tx date 2018-11-15
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,398
+3,575 vol
$1.51 each
81,181
Filed 2018-11-20
Tx date 2018-11-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,873
+2,565 vol
$1.51 each
179,381
Filed 2018-11-20
Tx date 2018-11-15
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$499.81
+331 vol
$1.51 each
3,714
Filed 2018-10-19
Tx date 2018-10-15
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$499.80
+196 vol
$2.55 each
3,383
Filed 2018-10-19
Tx date 2018-10-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$846.60
+332 vol
$2.55 each
37,345
Filed 2018-10-19
Tx date 2018-10-15
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,398
+2,117 vol
$2.55 each
77,606
Filed 2018-10-19
Tx date 2018-10-15
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,262
+495 vol
$2.55 each
21,735
Filed 2018-10-19
Tx date 2018-10-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,886
+1,524 vol
$2.55 each
176,816
Filed 2018-09-20
Tx date 2018-09-17
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,395
+1,934 vol
$2.79 each
75,489
Filed 2018-09-19
Tx date 2018-09-17
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,674
+1,317 vol
$2.79 each
175,292
Filed 2018-09-19
Tx date 2018-09-17
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$499.41
+179 vol
$2.79 each
3,187
Filed 2018-09-19
Tx date 2018-09-17
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$845.37
+303 vol
$2.79 each
37,013
Filed 2018-09-19
Tx date 2018-09-17
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$463.61
+179 vol
$2.59 each
Filed 2018-09-19
Tx date 2018-09-17
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,263
+453 vol
$2.79 each
21,240
Filed 2018-08-28
Tx date 2018-08-23
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+2,151 vol
3,008
Filed 2018-08-28
Tx date 2018-08-23
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-2,151 vol
27,198
Filed 2018-08-20
Tx date 2018-08-14
$CPH
Cipher Pharmaceuticals Inc.
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$60,800
+20,000 vol
$3.04 each
20,000
Filed 2018-08-20
Tx date 2018-08-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,623
+1,399 vol
$2.59 each
173,975
Filed 2018-08-20
Tx date 2018-08-15
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$499.87
+193 vol
$2.59 each
857
Filed 2018-08-20
Tx date 2018-08-14
$CPH
Cipher Pharmaceuticals Inc.
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+1,500 vol
1,500
Filed 2018-08-20
Tx date 2018-05-11
$CPH
Cipher Pharmaceuticals Inc.
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2018-08-20
Tx date 2018-08-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$844.34
+326 vol
$2.59 each
36,710
Filed 2018-08-20
Tx date 2018-08-15
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,394
+2,083 vol
$2.59 each
73,555
Filed 2018-08-20
Tx date 2018-08-15
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,263
+488 vol
$2.59 each
20,787
Filed 2018-08-20
Tx date 2018-05-11
$CPH
Cipher Pharmaceuticals Inc.
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-08-15
Tx date 2018-08-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,600
+2,000 vol
$2.80 each
36,384
Filed 2018-08-14
Tx date 2018-06-04
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-08-14
Tx date 2018-08-14
$CPH
Cipher Pharmaceuticals Inc.
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$169,452
+55,741 vol
$3.04 each
55,741
Filed 2018-07-20
Tx date 2018-07-16
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,416
+2,276 vol
$2.38 each
71,472
Filed 2018-07-19
Tx date 2018-07-16
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$844.90
+355 vol
$2.38 each
34,384
Filed 2018-07-19
Tx date 2018-07-16
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,619
+1,521 vol
$2.38 each
172,576
Filed 2018-07-19
Tx date 2018-07-16
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$499.80
+210 vol
$2.38 each
664
Filed 2018-07-19
Tx date 2018-07-16
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,261
+530 vol
$2.38 each
20,299
Filed 2018-07-05
Tx date 2018-06-25
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Performance Share Units
57 - Exercise of rights

-3,582 vol
23,216
Filed 2018-07-05
Tx date 2018-06-25
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$9,993
+3,582 vol
$2.79 each
19,769
Filed 2018-07-02
Tx date 2018-06-28
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$22,620
+7,800 vol
$2.90 each
385,115
Filed 2018-06-28
Tx date 2018-06-25
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$28,000
+10,000 vol
$2.80 each
377,315
Filed 2018-06-26
Tx date 2018-06-22
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,050
+2,200 vol
$2.75 each
367,315
Filed 2018-06-22
Tx date 2018-06-22
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,700
+2,000 vol
$2.85 each
34,029
Filed 2018-06-21
Tx date 2018-06-21
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,700
+2,000 vol
$2.85 each
32,029
Filed 2018-06-19
Tx date 2018-06-15
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,263
+547 vol
$2.31 each
16,187
Filed 2018-06-19
Tx date 2018-06-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$845.46
+366 vol
$2.31 each
30,029
Filed 2018-06-19
Tx date 2018-06-15
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,128
+2,220 vol
$2.31 each
69,196
Filed 2018-06-19
Tx date 2018-06-15
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$498.96
+216 vol
$2.31 each
454
Filed 2018-06-19
Tx date 2018-06-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,640
+1,576 vol
$2.31 each
171,055
Filed 2018-06-08
Tx date 2018-06-08
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,430
+2,000 vol
$2.71 each
29,663
Filed 2018-06-05
Tx date 2018-06-05
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,100
+2,000 vol
$3.05 each
27,663
Filed 2018-05-21
Tx date 2018-05-15
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,262
+425 vol
$2.97 each
15,640
Filed 2018-05-21
Tx date 2018-05-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$778.14
+262 vol
$2.97 each
20,663
Filed 2018-05-21
Tx date 2018-05-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,356
+1,130 vol
$2.97 each
169,479
Filed 2018-05-21
Tx date 2018-05-15
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$498.96
+168 vol
$2.97 each
238
Filed 2018-05-18
Tx date 2018-05-15
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,754
+1,601 vol
$2.97 each
66,976
Filed 2018-05-17
Tx date 2018-05-17
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$17,925
+5,000 vol
$3.58 each
25,401
Filed 2018-04-20
Tx date 2018-04-16
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$844.88
+236 vol
$3.58 each
20,401
Filed 2018-04-20
Tx date 2018-04-16
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,029
+1,405 vol
$3.58 each
65,375
Filed 2018-04-20
Tx date 2017-06-12
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-20
Tx date 2018-04-16
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,263
+353 vol
$3.58 each
15,215
Filed 2018-04-20
Tx date 2018-04-16
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,622
+1,012 vol
$3.58 each
168,349
Filed 2018-04-20
Tx date 2018-04-16
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$250.60
+70 vol
$3.58 each
70
Filed 2018-04-08
Tx date 2018-04-05
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,500 vol
63,970
Filed 2018-04-08
Tx date 2018-04-05
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
1,500
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,500 vol
104,300
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
1,500
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,500 vol
167,337
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-4,113 vol
55,671
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+4,113 vol
37,013
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
1,500
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,500 vol
365,115
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-3,582 vol
40,096
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-4,769 vol
43,678
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-4,769 vol
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,582 vol
14,862
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+4,769 vol
11,280
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$17,025
+4,769 vol
$3.57 each
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
1,500
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,500 vol
20,165
Filed 2018-04-06
Tx date 2018-04-03
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-1,500 vol
1,500
Filed 2018-03-28
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+1,500 vol
3,000
Filed 2018-03-28
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
Options
50 - Grant of options
$12,355
+3,500 vol
$3.53 each
29,500
Filed 2018-03-26
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+20,745 vol
Filed 2018-03-26
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+20,745 vol
29,349
Filed 2018-03-26
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+43,334 vol
59,784
Filed 2018-03-26
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$698,989
+198,014 vol
$3.53 each
288,014
Filed 2018-03-26
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+22,213 vol
48,447
Filed 2018-03-26
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$358,295
+101,500 vol
$3.53 each
226,544
Filed 2018-03-26
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+1,500 vol
3,000
Filed 2018-03-26
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$12,355
+3,500 vol
$3.53 each
27,000
Filed 2018-03-26
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+1,500 vol
3,000
Filed 2018-03-26
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$12,355
+3,500 vol
$3.53 each
23,500
Filed 2018-03-26
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+1,500 vol
3,000
Filed 2018-03-26
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$12,355
+3,500 vol
$3.53 each
27,000
Filed 2018-03-26
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$143,406
+40,625 vol
$3.53 each
Filed 2018-03-26
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$143,406
+40,625 vol
$3.53 each
75,995
Filed 2018-03-26
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+1,500 vol
3,000
Filed 2018-03-26
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$12,355
+3,500 vol
$3.53 each
27,000
Filed 2018-03-23
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$47,190
+13,000 vol
$3.63 each
18,665
Filed 2018-03-23
Tx date 2018-03-22
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$181,500
+50,000 vol
$3.63 each
165,837
Filed 2018-03-20
Tx date 2018-03-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$845.00
+250 vol
$3.38 each
5,665
Filed 2018-03-20
Tx date 2018-03-15
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,029
+1,488 vol
$3.38 each
62,470
Filed 2018-03-20
Tx date 2018-03-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,623
+1,072 vol
$3.38 each
115,837
Filed 2018-03-20
Tx date 2018-03-15
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,206
+357 vol
$3.38 each
6,511
Filed 2018-02-20
Tx date 2018-02-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,621
+1,059 vol
$3.42 each
114,765
Filed 2018-02-20
Tx date 2018-02-15
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,207
+353 vol
$3.42 each
6,154
Filed 2018-02-20
Tx date 2018-02-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$844.74
+247 vol
$3.42 each
5,415
Filed 2018-02-20
Tx date 2018-02-15
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,023
+1,469 vol
$3.42 each
60,982
Filed 2018-01-19
Tx date 2018-01-15
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,995
+1,350 vol
$3.70 each
59,513
Filed 2018-01-17
Tx date 2018-01-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$847.30
+229 vol
$3.70 each
5,168
Filed 2018-01-17
Tx date 2018-01-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,607
+975 vol
$3.70 each
113,706
Filed 2018-01-17
Tx date 2018-01-15
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,206
+326 vol
$3.70 each
5,801
Filed 2017-12-20
Tx date 2017-12-15
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,373
+1,357 vol
$3.96 each
58,163
Filed 2017-12-19
Tx date 2017-12-15
$CPH
Cipher Pharmaceuticals Inc.
Godin, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$784.08
+198 vol
$3.96 each
4,939
Filed 2017-12-19
Tx date 2017-12-15
$CPH
Cipher Pharmaceuticals Inc.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,864
+976 vol
$3.96 each
112,731
Filed 2017-12-19
Tx date 2017-12-15
$CPH
Cipher Pharmaceuticals Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,207
+305 vol
$3.96 each
5,475
Filed 2017-11-19
Tx date 2017-11-15
$CPH
Cipher Pharmaceuticals Inc.
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,376
+1,393 vol
$3.86 each
56,806
Filed 2017-11-17
Tx date 2017-11-15
$CPH
Cipher Pharmaceuticals Inc.